The global substance abuse disorder treatment market size was estimated to be USD 11.46 billion in 2023 and is expected to reach at USD 34.13 billion by 2034 with a CAGR of 10.43% during the forecast period 2024-2034. Rising prevalence of substance abuse disorders, growing awareness regarding the treatments, increasing supportive government initiatives such as drug awareness campaigns & prevention programs, surge in prevalence of opioid use disorders, rising adoption of Nicotine Replacement Therapy (NRT), increasing technological developments in therapies, surge in launch of awareness programs are some of the major elements driving the market's expansion.
Surge in launch of awareness programs is predicted to boost the market growth during the forecast period. The growing prevalence of addiction within the population underscores the importance of raising awareness about the dangers posed by illegal drugs to one's health. Both public and private entities are consistently dedicated to arranging campaigns and initiatives aimed at educating individuals about the adverse consequences of substance abuse. These efforts also aim to encourage addicts to seek addiction treatment. For instance, in March 2022, The Texas Health and Human Services department has initiated a public awareness campaign with a budget of $23.2 million. The campaign aims to prevent substance abuse disorders and facilitate access to addiction treatment and related services.
By treatment, tobacco/nicotine & vaping was the highest revenue-grossing segment in the global substance abuse disorder treatment market in 2023 owing to rising prevalence of tobacco addiction among the population, surge in impairment of the lungs & decreased lung function, growing need for addiction treatment for various health conditions, increasing strategic initiatives by several market players, and rising launch of new products. For instance, in February 2023, Sesh+, a company focused on smoking cessation and committed to preventing addiction while offering treatment, has created nicotine replacement therapy (NRT) products in flavors like cinnamon, pomegranate, and wintergreen to encourage the use of treatment. Additionally, alcohol is predicted to grow at fastest CAGR during the forecast period owing to its rising consumption, easy availability, & increased acceptability in society, growing prevalence of chronic diseases, and increasing launch of new products by major market players.
By end-user, hospital was the highest revenue-grossing segment in the global substance abuse disorder treatment market in 2023 owing to the delayed diagnosis of the illness due to social stigmatization among patients causing unwillingness to receive treatment, which frequently leads in severe addiction cases requiring hospitalization to provide the user with the necessary addiction therapies and hospitals serving as major treatment facilities for people with long-term drug use problems who frequently acquire comorbid illnesses such cancer, heart disease, stroke, lung disease, HIV/AIDS, Hepatitis B & C, & mental disorders. Additionally, rehabilitation centers is predicted to grow at fastest CAGR during the forecast period owing to heading to a rehabilitation clinic is a better option for people who have to go through long-term addiction therapy, which can last anywhere from six months and a year or more and increasing collaborations within market players, and surge in launch of advanced treatment. For instance, in February 2023, Jovive Health has introduced Medication-Assisted Treatment (MAT) aimed at alleviating the impact of opioid dependence in individuals diagnosed with Opioid Use Disorders (OUD).
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing number of people exposed to addiction, rising reimbursement policies, surge in nicotine addiction among population, growing government initiatives aimed at reducing substance abuse, and increasing product approvals by regulatory bodies. For instance, in March 2023, The U.S. Food and Drug Administration granted approval for Narcan, a nasal spray containing naloxone hydrochloride, to be available over-the-counter (OTC) without a prescription. This marks the first approval of a naloxone product for nonprescription use. The standard therapy for such cases is naloxone, a drug that quickly reverses the symptoms of an opioid overdose. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising focus on spreading awareness regarding the serious threats associated with substance abuse, growing healthcare infrastructure, surge in prevalence of tobacco, alcohol, & opioid addiction, increasing government initiatives for the adoption of improve treatment for drug addiction. For instance, in February 2023, The Ministry of Social Justice and Empowerment (MoSJE) has initiated the Addiction Treatment Facility (ATF) program, which is being overseen on a national level by the National Drug Dependence Treatment Centre (NDDTC) at AIIMS in New Delhi. MoSJE has designated 125 districts across the country for the establishment of ATFs. The program is in the process of expansion, and the ministry is collaborating with different state governments and district administrations to identify hospitals suitable for setting up ATFs.
Surge in launch of awareness programs is predicted to boost the market growth during the forecast period. The growing prevalence of addiction within the population underscores the importance of raising awareness about the dangers posed by illegal drugs to one's health. Both public and private entities are consistently dedicated to arranging campaigns and initiatives aimed at educating individuals about the adverse consequences of substance abuse. These efforts also aim to encourage addicts to seek addiction treatment. For instance, in March 2022, The Texas Health and Human Services department has initiated a public awareness campaign with a budget of $23.2 million. The campaign aims to prevent substance abuse disorders and facilitate access to addiction treatment and related services.
By treatment, tobacco/nicotine & vaping was the highest revenue-grossing segment in the global substance abuse disorder treatment market in 2023 owing to rising prevalence of tobacco addiction among the population, surge in impairment of the lungs & decreased lung function, growing need for addiction treatment for various health conditions, increasing strategic initiatives by several market players, and rising launch of new products. For instance, in February 2023, Sesh+, a company focused on smoking cessation and committed to preventing addiction while offering treatment, has created nicotine replacement therapy (NRT) products in flavors like cinnamon, pomegranate, and wintergreen to encourage the use of treatment. Additionally, alcohol is predicted to grow at fastest CAGR during the forecast period owing to its rising consumption, easy availability, & increased acceptability in society, growing prevalence of chronic diseases, and increasing launch of new products by major market players.
By end-user, hospital was the highest revenue-grossing segment in the global substance abuse disorder treatment market in 2023 owing to the delayed diagnosis of the illness due to social stigmatization among patients causing unwillingness to receive treatment, which frequently leads in severe addiction cases requiring hospitalization to provide the user with the necessary addiction therapies and hospitals serving as major treatment facilities for people with long-term drug use problems who frequently acquire comorbid illnesses such cancer, heart disease, stroke, lung disease, HIV/AIDS, Hepatitis B & C, & mental disorders. Additionally, rehabilitation centers is predicted to grow at fastest CAGR during the forecast period owing to heading to a rehabilitation clinic is a better option for people who have to go through long-term addiction therapy, which can last anywhere from six months and a year or more and increasing collaborations within market players, and surge in launch of advanced treatment. For instance, in February 2023, Jovive Health has introduced Medication-Assisted Treatment (MAT) aimed at alleviating the impact of opioid dependence in individuals diagnosed with Opioid Use Disorders (OUD).
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing number of people exposed to addiction, rising reimbursement policies, surge in nicotine addiction among population, growing government initiatives aimed at reducing substance abuse, and increasing product approvals by regulatory bodies. For instance, in March 2023, The U.S. Food and Drug Administration granted approval for Narcan, a nasal spray containing naloxone hydrochloride, to be available over-the-counter (OTC) without a prescription. This marks the first approval of a naloxone product for nonprescription use. The standard therapy for such cases is naloxone, a drug that quickly reverses the symptoms of an opioid overdose. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising focus on spreading awareness regarding the serious threats associated with substance abuse, growing healthcare infrastructure, surge in prevalence of tobacco, alcohol, & opioid addiction, increasing government initiatives for the adoption of improve treatment for drug addiction. For instance, in February 2023, The Ministry of Social Justice and Empowerment (MoSJE) has initiated the Addiction Treatment Facility (ATF) program, which is being overseen on a national level by the National Drug Dependence Treatment Centre (NDDTC) at AIIMS in New Delhi. MoSJE has designated 125 districts across the country for the establishment of ATFs. The program is in the process of expansion, and the ministry is collaborating with different state governments and district administrations to identify hospitals suitable for setting up ATFs.
Segmentation: Substance Abuse Disorder Treatment Market Report 2022 - 2033
Substance Abuse Disorder Treatment Market Analysis & Forecast by Treatment 2023 - 2034 (Revenue USD Bn)
- Synthetic Cannabinoids
- Marijuana
- Alcohol
- Tobacco/Nicotine & Vaping
- Prescription and Over-the-counter Medications
- Others
Substance Abuse Disorder Treatment Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Rehabilitation Centers
- Clinics
- Hospitals
- Others
Substance Abuse Disorder Treatment Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Substance Abuse Disorder Treatment Market: Treatment Estimates & Trend Analysis
8. Substance Abuse Disorder Treatment Market: End-user Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Substance Abuse Disorder Treatment Market
11. Europe Global Substance Abuse Disorder Treatment Market
12. Asia Pacific Global Substance Abuse Disorder Treatment Market
13. Latin America Global Substance Abuse Disorder Treatment Market
14. MEA Global Substance Abuse Disorder Treatment Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Novartis AG
- Viatris Inc.
- Abbott
- JB Chemicals & Pharmaceuticals Ltd
- GSK plc.
- Jovive Health
- Lilly (Eli Lilly and Company)
- Cipla Inc.
- AstraZeneca
- NFL Biosciences
- Sun Pharmaceutical Industries Ltd.
- Dr. Reddy’s Laboratories Ltd.
- Teva Pharmaceutical Industries Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | October 2023 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 11.46 Billion |
| Forecasted Market Value ( USD | $ 34.13 Billion |
| Compound Annual Growth Rate | 10.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
